Definitive Healthcare Corp.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | — |
| Cost of revenue | $58.2M | $54.7M | $47.5M | $42.6M | — |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | — |
| Research and development | $34.8M | $36.5M | $42.4M | $34.9M | — |
| Operating expenses | $407.5M | $908.3M | $533.7M | $224.1M | — |
| Operating income | -$224.3M | -$710.8M | -$329.8M | -$44.0M | — |
| Interest expense | $11.3M | $14.8M | $15.2M | $11.2M | — |
| Pretax income | -$209.3M | -$633.7M | -$308.2M | -$41.9M | — |
| Income tax expense | -$10.0M | -$42.3M | -$18.6M | -$17.7M | — |
| Net income | -$138.9M | -$413.1M | -$202.4M | -$7.2M | — |
| Balance Sheet | |||||
| Cash and equivalents | $163.6M | $105.4M | $131.0M | $146.9M | — |
| Current assets | $257.6M | $370.2M | $393.9M | $413.7M | — |
| Total assets | $735.5M | $1.1B | $1.8B | $2.1B | $2.1B |
| Current liabilities | $156.8M | $161.2M | $170.7M | $140.6M | $128.8M |
| Total liabilities | $356.5M | $482.2M | $626.7M | $640.7M | $648.3M |
| Stockholders' equity | $379.0M | $607.2M | $1.2B | $1.5B | $1.5B |
| Cash Flow Statement | |||||
| Cash from operations | $53.8M | $58.2M | $41.2M | $35.6M | — |
| Depreciation and amortization | $3.3M | $2.2M | $2.0M | $2.2M | — |
| Stock-based compensation | $29.1M | $38.1M | $48.7M | $36.4M | — |
| Capital expenditure | $16.7M | $12.3M | $3.0M | $8.3M | — |
| Free cash flow | $37.1M | $45.9M | $38.2M | $27.3M | — |
| Share repurchases | $49.5M | $22.4M | $0 | $0 | — |
| Impairments | $196.1M | $1.2M | $287.4M | $0 | — |
Shares outstanding 105.5M
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.